Latest Breaking News On - Arthritis rheumatol - Page 2 : vimarsana.com

Johnson & Johnson : TREMFYA® (guselkumab) Provides Sustained Improvements Across All Minimal Disease Activity Domains for Adults Living with Active Psoriatic Arthritis in Phase 3b Trial

SPRING HOUSE, PENNSYLVANIA, May 31, 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 3b COSMOS clinical trial showing that treatment. | May 31, 2023

United statesSpring houseZismand comorbiditiesLaura coatesTerence rooneyCraig stoltzScandj rheumatolNational library of medicineStanford health assessment questionnaireCanadian agency for drugs technologies in healthJanssen scientific affairsJanssen pharmaceutical companiesArthritis foundationDevices agencyExchange commissionJanssen pharmaceutical companies of johnson

The role of autoantibodies biomarkers in precision medicine

This article outlines the powerful role of biomarkers in precision medicine, such as the use of autoantibodies for drug discovery against cancer.

United statesNat genetGama duarteVan normanMaria osipovaClin rheumatolKlunket alVan regenmortelHigh mobility group nucleosome binding domainNational cancer instituteSponsored contentHumoral immuneTestis antigenTestis specific proteiny linkedCancer testis antigenMobility group nucleosome binding domain

A call to action: setting the future care principles for people living with Systemic Lupus Erythematosus

Lupus Awareness Month 2022: Advocates for the 5 million people worldwide living with this often-debilitating autoimmune disease set the bar for quality care and better futures for patients.

United statesUnited kingdomCyrus cooperAl sawahLiliana ribeiroLupus pillars for health advancementHealth programBritish society of rheumatologyWorld lupus federationCenters for disease preventionEuropean reference networkLupus foundation of americaSectional onlineEuropean commissionPeuropean league against rheumatismBritish society for rheumatology

ILD Screening in Rheumatic Diseases: Strategies to Consider

Two experts from Hospital for Special Surgery review the current landscape and evidence for interstitial lung disease screening in patients with connective tissue diseases.

New yorkUnited statesHospital for special surgeryUnited kingdomVazquez rodriguezJessicak gordonKimberly showalterWeill cornell medical collegeRisk factorsAfrican americanSpecial surgeryLung diseaseIdiopathic inflammatoryCurr rheumatol revPulmonary function testsHigh rate

FDA approves Octapharma s Octagam® 10% for adult dermatomyositis

FDA approves Octapharma s Octagam® 10% for adult dermatomyositis
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Switzerland generalUnited kingdomFlemming nielsenRohit aggarwalNational centerSteering committeeUniversity of pittsburgh school medicineNational institutes of healthOctapharma groupDrug administrationAmerican college of rheumatologyPeuropean league against rheumatismTranslational sciencesUs department of health human servicesAutoimmunity centerOctapharma united states